133 related articles for article (PubMed ID: 18424889)
1. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
Sato E; Fujimoto J; Tamaya T
Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889
[TBL] [Abstract][Full Text] [Related]
2. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
3. Expression of IP-10 related to angiogenesis in uterine cervical cancers.
Sato E; Fujimoto J; Toyoki H; Sakaguchi H; Alam SM; Jahan I; Tamaya T
Br J Cancer; 2007 Jun; 96(11):1735-9. PubMed ID: 17505511
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers.
Fujimoto J; Toyoki H; Sato E; Sakaguchi H; Jahan I; Alam SM; Tamaya T
J Biomed Sci; 2006 Nov; 13(6):825-32. PubMed ID: 17013750
[TBL] [Abstract][Full Text] [Related]
5. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
6. [Expression of basic fibroblastic growth factor and microvessel density in endometrial carcinoma].
Bai X; Mi R
Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):348-51. PubMed ID: 11776176
[TBL] [Abstract][Full Text] [Related]
7. Vascular proliferation is important for clinical progress of endometrial cancer.
Stefansson IM; Salvesen HB; Akslen LA
Cancer Res; 2006 Mar; 66(6):3303-9. PubMed ID: 16540684
[TBL] [Abstract][Full Text] [Related]
8. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers.
Fujimoto J; Aoki I; Khatun S; Toyoki H; Tamaya T
Ann Oncol; 2002 Mar; 13(3):430-4. PubMed ID: 11996475
[TBL] [Abstract][Full Text] [Related]
10. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Tamaya T
Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers.
Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T
Ann Oncol; 2002 Oct; 13(10):1605-11. PubMed ID: 12377649
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer.
Fujimoto J; Toyoki H; Sakaguchi H; Jahan I; Alam SM; Tamaya T
Oncol Rep; 2006 Jan; 15(1):21-5. PubMed ID: 16328030
[TBL] [Abstract][Full Text] [Related]
13. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
[TBL] [Abstract][Full Text] [Related]
15. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer.
Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA
Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287
[TBL] [Abstract][Full Text] [Related]
16. The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor.
Demirkesen C; Büyükpinarbaşili N; Ramazanoğlu R; Oğuz O; Mandel NM; Kaner G
Pathology; 2006 Apr; 38(2):132-7. PubMed ID: 16581653
[TBL] [Abstract][Full Text] [Related]
17. The effect of COX-2 inhibitor, nimesulide, on angiogenetic factors in primary endometrial carcinoma cell culture.
Genç S; Attar E; Gürdöl F; Kendigelen S; Bilir A; Serdaroğlu H
Clin Exp Med; 2007 Mar; 7(1):6-10. PubMed ID: 17380299
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma.
Guşet G; Costi S; Lazăr E; Dema A; Cornianu M; Vernic C; Păiuşan L
Rom J Morphol Embryol; 2010; 51(4):677-82. PubMed ID: 21103625
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers.
Toyoki H; Fujimoto J; Sato E; Sakaguchi H; Tamaya T
Ann Oncol; 2005 Jan; 16(1):51-5. PubMed ID: 15598938
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and Bcl-2 protein expression in patients with endometrial carcinoma.
Mazurek A; Pierzynski P; Niklinska W; Chyczewski L; Laudanski T
Neoplasma; 2002; 49(3):149-54. PubMed ID: 12097999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]